Head and Neck Neoplasms: all 2,403 studies

Page 8 of 25. Open to participants first (559), then studies with results posted, then the rest; newest registration first within each.

• NewBreez for Airway Protection in Head and Neck Cancer Patients With Chronic AspirationTerminatedNCT02437513Results posted
• Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS MutationsCompletedNCT02383927Phase 2Results posted
• Modified Dakin's Solution in Reducing Radiation-Induced Dermatitis in Patients With Head and Neck Cancer Undergoing Radiation TherapyCompletedNCT02369835Phase 3Results posted
• Pain Control Using Neuromodulation in Patients Undergoing Definitive Chemoradiotherapy for Head and Neck CancerCompletedNCT02366611Not applicableResults posted
• A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048)CompletedNCT02358031Phase 3Results posted
• Tissue and Hematopoietic/Mesenchymal Stem Cell for Humanized Xenograft Studies in Melanoma and Squamous Head and Neck CancerCompletedNCT02331134Not applicableResults posted
• A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)CompletedNCT02327078Phase 1/2Results posted
• Study of the Effects of Brilacidin Oral Rinse on Radiation-induced Oral Mucositis in Patients With Head and Neck CancerCompletedNCT02324335Phase 2Results posted
• A Study of Epacadostat (INCB024360) in Combination With Durvalumab (MEDI4736) in Subjects With Selected Advanced Solid Tumors (ECHO-203)CompletedNCT02318277Phase 1/2Results posted
• Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell CarcinomaCompletedNCT02296684Phase 2Results posted
• A Study of ADXS11-001 or MEDI4736 Alone or Combination In Cervical or Human Papillomavirus (HPV)+ Head & Neck CancerTerminatedNCT02291055Phase 1/2Results posted
• Reirradiation With Pembrolizumab in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and NeckCompletedNCT02289209Phase 2Results posted
• De-intensification of Radiation and Chemotherapy for Low-Risk HPV-related Oropharyngeal SCC: Follow-up StudyCompletedNCT02281955Phase 2Results posted
• Pembrolizumab (MK-3475) Versus Standard Treatment for Recurrent or Metastatic Head and Neck Cancer (MK-3475-040/KEYNOTE-040)CompletedNCT02252042Phase 3Results posted
• A Prospective Study Evaluating the Use of Intraoperative Stroke Volume Variation Via the FloTrac Device to Guide Fluid and Vasopressor Management in Head and Neck Free FlapsCompletedNCT02186938Not applicableResults posted
• LUX-Head & Neck 4: Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapyTerminatedNCT02131155Phase 3Results posted
• A Study of Chemo +/- Low-dose Radiation as Induction Therapy in SCCHNCompletedNCT02126969Phase 2Results posted
• Weekly Carboplatin, Paclitaxel and Cetuximab Treatment for Patients With Recurrent or Metastatic SCCHNCompletedNCT02124707Phase 2Results posted
• Image-guided Cryoablation of Head, Neck and Spine TumorsCompletedNCT02085941Not applicableResults posted
• A Phase 2 Trial of Rebamipide Liquid to Determine the Effective Dose for Prevention of Chemoradiotherapy-induced Oral Mucositis in Patients With Head and Neck CancerCompletedNCT02085460Phase 2Results posted
• Randomized Study of Beet Root in Locally Advanced Squamous Cell Cancer of the Head and NeckCompletedNCT02058849Phase 2Results posted
• Minocycline for Postsurgical Symptom Reduction in Head and Neck CancerTerminatedNCT02055963Phase 2Results posted
• ADXS 11-001 Vaccination Prior to Robotic Surgery, HPV-Positive Oropharyngeal CancerCompletedNCT02002182Phase 2Results posted
• Post-operative Radiation With Cetuximab for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and NeckCompletedNCT01979211Phase 2Results posted
• Study of Personalized Sterile Humidification Device for Mucositis in Head and Neck Cancer PatientsCompletedNCT01930435Not applicableResults posted
• Study of Chemotherapy With Cisplatin/Carboplatin, and Docetaxel With or Without Erlotinib in Patients With Head and Neck Squamous Cell Carcinomas Amenable for Surgical ResectionCompletedNCT01927744Phase 2Results posted
• LUX-Head&Neck 3: Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer After Platinum Based ChemotherapyCompletedNCT01856478Phase 3Results posted
• Image-Guided Adaptive Radiotherapy for in Detecting Tumors During Treatment in Patients With Head and Neck CancerCompletedNCT01843673Not applicableResults posted
• PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT01816984Phase 1/2Results posted
• 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis TherapyCompletedNCT01806675Phase 1/2Results posted
• Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck CarcinomaTerminatedNCT01794845Phase 2Results posted
• Use of Pharmacogenetics to Select Erbitux or Cisplatin to Treat Head and Neck CancerTerminatedNCT01790516Not applicableResults posted
• Reproducibility of Intratumor Distribution of 18F-EF5 in Head and Neck CancerCompletedNCT01774760Phase 2Results posted
• Laser Mucite ORL : Effectiveness of Laser Therapy for Mucositis Induced by a Radio-chemotherapy in Head and Neck CancerCompletedNCT01772706Not applicableResults posted
• MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to TreatmentCompletedNCT01770353Phase 1Results posted
• Ponatinib for Squamous Cell Lung and Head and Neck CancersTerminatedNCT01761747Phase 2/3Results posted
• A Dose Finding Study of Eribulin Mesylate and Cetuximab For Patients With Advanced Head and Neck and Colon CancerCompletedNCT01744340Phase 1/2Results posted
• Induction Chemotherapy Followed by Chemoradiotherapy for Head and Neck CancerCompletedNCT01716195Phase 2Results posted
• TRYHARD: Radiation Therapy Plus Cisplatin With or Without Lapatinib in Treating Patients With Head and Neck Cancer.CompletedNCT01711658Phase 2Results posted
• Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed by SurgeryCompletedNCT01696955Phase 2Results posted
• A Study Using Cone Beam CT for Head and Neck CancerCompletedNCT01661062Not applicableResults posted
• Analgesic Effects of Topical Ketamine Mouthwash in Patients Receiving Chemoradiation or Radiotherapy for Head & Neck CancerCompletedNCT01653327Phase 2Results posted
• Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral SurgeryCompletedNCT01612351Phase 2Results posted
• Bevacizumab/Ph 2 for Locally Advanced Head and Neck CancerCompletedNCT01588431Phase 2Results posted
• Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck CancerCompletedNCT01581970Phase 2Results posted
• Feasibility of IMRT Modulation to Account for Scattered Radiation From Dental Fillings in Head and Neck CancerCompletedNCT01576939Not applicableResults posted
• Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck CancerCompletedNCT01566435Phase 2Results posted
• Positron Emission Tomography/Magnetic Resonance Imaging in PatientsTerminatedNCT01557881Not applicableResults posted
• De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell CaCompletedNCT01530997Phase 2Results posted
• Impact of Applying a Bandage Skin Hydrogel on the Pains of the Head and Neck in Patients With Cancer of Head and Neck Treated With RadiotherapyCompletedNCT01520701Phase 3Results posted
• Imaging Study for FdCyd and THU Cancer TreatmentTerminatedNCT01479348Early Phase 1Results posted
• Phase II Trial Evaluating Axitinib In Patients With Unresectable, Recurrent Or Metastatic Head And Neck CancerCompletedNCT01469546Phase 2Results posted
• Optical Imaging of Head and Neck CancerTerminatedNCT01456143Not applicableResults posted
• A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced CancersCompletedNCT01451632Phase 1Results posted
• Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN)CompletedNCT01437449Phase 2Results posted
• Interstitial Photodynamic Therapy (PDT) With Temoporfin for Advanced Head and Neck CancersTerminatedNCT01415986Phase 2Results posted
• Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and NeckCompletedNCT01412229Phase 2Results posted
• Safety and Efficacy of ALD518 for Reducing Oral Mucositis in Head and Neck Cancer SubjectsTerminatedNCT01403064Phase 2Results posted
• LUX-Head&Neck 1: A Phase III Trial of Afatinib (BIBW2992) Versus Methotrexate for the Treatment of Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Cancer After Platinum Based ChemotherapyCompletedNCT01345682Phase 3Results posted
• LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapyTerminatedNCT01345669Phase 3Results posted
• Stereotactic Body Radiotherapy for Head and Neck TumorsCompletedNCT01344356Phase 4Results posted
• Single Agent Armodafinil for Patient-Reported Fatigue Following Radiation Therapy for Head and Neck CancerCompletedNCT01330446Phase 1/2Results posted
• Safety Study of Adenovirus/PNP Coupled With Fludarabine Phosphate to Treat Solid TumorsCompletedNCT01310179Phase 1Results posted
• Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal CancerCompletedNCT01302834Phase 3Results posted
• To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung CancerTerminatedNCT01284348Phase 2Results posted
• A Study of Carboplatin, Cetuximab and RAD001 in Advanced Head and Neck CancerCompletedNCT01283334Phase 1/2Results posted
• Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous TherapyCompletedNCT01256385Phase 2Results posted
• Symptom Burden in Head and Neck CancerTerminatedNCT01219673Phase 1/2Results posted
• Rapamycin Therapy in Head and Neck Squamous Cell CarcinomaCompletedNCT01195922Phase 1/2Results posted
• Transcutaneous Electrical Nerve Stimulation (TENS) and Head and Neck Cancer Pain (HNC) (TENS & HNC)CompletedNCT01194466Not applicableResults posted
• Erlotinib Hydrochloride and Radiation Therapy in Stage III-IV Squamous Cell Cancer of the Head and NeckTerminatedNCT01192815Phase 2Results posted
• Trial of Induction Chemotherapy With Carboplatin and Paclitaxel, Followed by Concurrent Chemotherapy/Radiation Therapy With ZD1839 (IRESSA), 5-FU, Hydroxyurea, and Twice-Daily Radiation, Followed by Adjuvant ZD1839 Monotherapy in Patients With Locally Advanced Head & Neck CancerCompletedNCT01185171Phase 2Results posted
• A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer TumorsCompletedNCT01171924Phase 1Results posted
• Nurse-led Follow-up Care for Head and Neck Cancer PatientsCompletedNCT01167179Not applicableResults posted
• Study of Safety and Efficacy of Talimogene Laherparepvec With Cisplatin and Radiotherapy for Treatment of Locally Advanced Head and Neck CancerTerminatedNCT01161498Phase 3Results posted
• Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without ChemotherapyCompletedNCT01156142Phase 3Results posted
• Comparison Between Internal and External Preoperative Biliary Drainage in Periampullary CancersCompletedNCT01134276Not applicableResults posted
• Everolimus Versus Placebo in Head and Neck CancerTerminatedNCT01111058Phase 2Results posted
• A Study for Participants With Recurrent or Metastatic Squamous Cell Head and Neck CancerCompletedNCT01087970Phase 2Results posted
• A Study in Head and Neck CancerCompletedNCT01081041Phase 2Results posted
• Study of [F 18]HX4 Positron Emission Tomography (PET) as a Tool to Detect Hypoxia in TumorsCompletedNCT01075399Phase 2Results posted
• Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and NeckCompletedNCT01065844Phase 2Results posted
• A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and NeckCompletedNCT01059643Phase 2Results posted
• Transoral Robotic Surgery (TORS) for Oral and Laryngopharyngeal Lesions Using Da Vinci Robotic Surgical SystemCompletedNCT01059357Not applicableResults posted
• A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck CancerCompletedNCT01057589Phase 2Results posted
• RAD001, Cisplatin and Concurrent Radiation for Locally Advanced, Inoperable Head and Neck CancerTerminatedNCT01057277Phase 1Results posted
• Zalutumumab Pharmacokinetics (PK) in Squamous Cell Carcinoma of the Head and Neck (SCCHN)CompletedNCT01054625Phase 1/2Results posted
• Capecitabine and Lapatinib Ditosylate in Treating Patients With Squamous Cell Cancer of the Head and NeckCompletedNCT01044433Phase 2Results posted
• EMD 1201081 in Combination With Cetuximab in Second-Line Cetuximab-Naïve Subjects With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT01040832Phase 2Results posted
• Study of Pazopanib and Ixabepilone in Patients With Solid TumorsTerminatedNCT01012362Phase 1Results posted
• RAD001 in Combination With Cetuximab and Cisplatin in Recurrent and Metastatic SCCHNTerminatedNCT01009346Phase 1/2Results posted
• A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine (FdCyd + THU)CompletedNCT00978250Phase 2Results posted
• Rollover Study of Weekly Paclitaxel (BMS-181339) in Patients With Head and Neck CancerCompletedNCT00971867Phase 2Results posted
• Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck CancerCompletedNCT00970502Phase 1/2Results posted
• RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck CancerActive, not recruitingNCT00956007Phase 3Results posted
• Trial of RAD001 and Erlotinib With Recurrent Head and Neck Squamous Cell CarcinomaCompletedNCT00942734Phase 2Results posted
• A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H...CompletedNCT00923481Phase 2Results posted
• Study of Radiation (RT) Concurrent With Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (SCC)TerminatedNCT00904345Phase 2Results posted
• Radiation Therapy and Cetuximab in Treating Patients With Recurrent Head and Neck CancerTerminatedNCT00891904Not applicableResults posted
• A Study of Dasatinib, Cetuximab and Radiation With or Without Cisplatin in HNSCCTerminatedNCT00882583Phase 1Results posted

← Head and Neck Neoplasms overview